Literature DB >> 863471

Temperature effects on lymphocyte transformation invitro.

R L Hirsch, B D Jeffries, I Gray.   

Abstract

Phytohemagglutinin (PHA)-induced transformation of normal rat peripheral lymphocytes has been studied at a wide range of culture temperatures (4 degrees C to 42 degrees C). Lymphocyte transformation was maximum at 37 degrees C while insignificant stimulation was observed between 4 degrees C and 30 degrees C. Temperatures above 37 degrees C produced sub=optimal transformation as measured by synthesis of DNA and protein, and appearance of lymphoblasts. Binding studies using 125I-PHA indicate that the low temperature inhibition of lymphocyte transformation could be a result of excess lectin (being available as a result of low temperature) bound to the cell surface, preventing the initiation of the molecular events associated with transformation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 863471     DOI: 10.3109/08820137709055804

Source DB:  PubMed          Journal:  Immunol Commun        ISSN: 0090-0877


  5 in total

1.  Subcellular distribution of transferrin-bound zinc incorporated by phytohemagglutinin-stimulated and unstimulated human lymphocytes.

Authors:  J L Phillips
Journal:  Biol Trace Elem Res       Date:  1980-12       Impact factor: 3.738

Review 2.  Temperature and host defense.

Authors:  N J Roberts
Journal:  Microbiol Rev       Date:  1979-06

3.  Depressed mitogen responsiveness of lymphocytes at skin temperature.

Authors:  M Lauwasser; J W Shands
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

4.  Leucocyte migration inhibition with Armadillo lepromin in human lymphocytes of healthy donors.

Authors:  D Fumarola; E Jirillo
Journal:  Infection       Date:  1978       Impact factor: 3.553

5.  The effects of variations in pH and temperature on the activation of mouse thymocytes by both forms of rabbit interleukin-1.

Authors:  P A Murphy; D F Hanson; Y N Guo; D E Angster
Journal:  Yale J Biol Med       Date:  1985 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.